Analysts Set Expectations for USANA Health Sciences, Inc.’s Q2 2024 Earnings (NYSE:USNA)

USANA Health Sciences, Inc. (NYSE:USNA) – Equities research analysts at DA Davidson issued their Q2 2024 EPS estimates for shares of USANA Health Sciences in a report issued on Tuesday, May 7th. DA Davidson analyst L. Weiser forecasts that the company will post earnings of $0.68 per share for the quarter. DA Davidson has a “Neutral” rating and a $46.00 price objective on the stock. The consensus estimate for USANA Health Sciences’ current full-year earnings is $2.75 per share.

Separately, StockNews.com raised USANA Health Sciences from a “buy” rating to a “strong-buy” rating in a research note on Friday, January 12th.

USANA Health Sciences Price Performance

Shares of USANA Health Sciences stock opened at $46.32 on Wednesday. USANA Health Sciences has a one year low of $41.45 and a one year high of $69.60. The business’s 50 day simple moving average is $46.38 and its two-hundred day simple moving average is $48.04. The stock has a market capitalization of $889.34 million, a P/E ratio of 14.43, a price-to-earnings-growth ratio of 1.38 and a beta of 0.94.

USANA Health Sciences (NYSE:USNA) last announced its quarterly earnings data on Tuesday, February 6th. The company reported $0.87 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.52 by $0.35. USANA Health Sciences had a net margin of 6.88% and a return on equity of 12.80%. The company had revenue of $221.08 million during the quarter, compared to analysts’ expectations of $206.70 million.

Insider Activity

In related news, insider David Mulham Mulham sold 4,311 shares of the company’s stock in a transaction that occurred on Thursday, February 29th. The stock was sold at an average price of $47.76, for a total value of $205,893.36. Following the transaction, the insider now directly owns 7,825 shares of the company’s stock, valued at approximately $373,722. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, insider Daniel A. Macuga sold 3,791 shares of the business’s stock in a transaction on Thursday, May 2nd. The shares were sold at an average price of $47.14, for a total transaction of $178,707.74. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider David Mulham Mulham sold 4,311 shares of the company’s stock in a transaction dated Thursday, February 29th. The stock was sold at an average price of $47.76, for a total value of $205,893.36. Following the completion of the sale, the insider now owns 7,825 shares of the company’s stock, valued at approximately $373,722. The disclosure for this sale can be found here. Insiders sold 34,286 shares of company stock worth $1,634,010 over the last three months. 0.33% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On USANA Health Sciences

Large investors have recently made changes to their positions in the business. Quest Partners LLC purchased a new position in shares of USANA Health Sciences in the fourth quarter valued at $66,000. CWM LLC increased its holdings in shares of USANA Health Sciences by 49.6% in the 4th quarter. CWM LLC now owns 1,267 shares of the company’s stock worth $68,000 after buying an additional 420 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its position in shares of USANA Health Sciences by 60.6% during the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,376 shares of the company’s stock valued at $198,000 after buying an additional 1,274 shares in the last quarter. Trexquant Investment LP bought a new position in shares of USANA Health Sciences in the 4th quarter valued at about $266,000. Finally, Teacher Retirement System of Texas purchased a new position in USANA Health Sciences in the third quarter worth about $297,000. 54.25% of the stock is currently owned by hedge funds and other institutional investors.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.